Whalegun
Home

Quang X. Pham, Chairman, CEO and Interim CFO: Cadrenal Therapeutics CVKD Sell · Filed 06/26

Trade details

Type
Insider sale
Amount
$27,538.45
Shares · price
9,029 sh · $3.05 a share
Held after
105,989 sh
Stock
Cadrenal Therapeutics CVKD
Person
Quang X. PhamChairman, CEO and Interim CFO
Trade date
26/06/26
Filed
26/06/26
Days to filing
0 days

Sold 7.9% of holdings

Share of holding sold
7.9%

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

Quang X. Pham's recent trades

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $6,381

    Filed 06/26

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $32.5K

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $7,286

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $11.5K

    Filed 06/18

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $1,621

    Filed 06/18

Quang X. Pham, Chairman — sold $27.5K of Cadrenal Therapeutics CVKD · 7.9% of holdings · 10b5-1 plan | Whalegun